Language selection

Government of Canada / Gouvernement du Canada

Search

NACI rapid response - interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada.: HP5-137/2022E-PDF ; HP5-137/1-2022E-PDF

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.911967&sl=0

Publication information
Department/Agency
  • Public Health Agency of Canada, issuing body.
  • Canada. National Advisory Committee on Immunization, issuing body.
TitleNACI rapid response - interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada.
Variant title
  • Interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada
  • National Advisory Committee on Immunization rapid response - interim guidance on the use of Imvamune® in the context of monkeypox outbreaks in Canada
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Réponse rapide du CCNI - orientations provisoires sur l'utilisation d'Imvamuneᴹᴰ dans le contexte des éclosions de variole simienne au Canada.
  • Cover title.
  • At head of title: An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI).
  • "Pub.: 220181."
  • "Pub.: 220197."
  • Issued also in HTML format.
  • Includes bibliographical references (pages 22-25).
Publishing information
  • Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, June 2022.
  • ©2022
Description1 online resource (25 pages) + summary (5 pages)
ISBN9780660439082 9780660439990
Catalogue number
  • HP5-137/2022E-PDF
  • HP5-137/1-2022E-PDF
Departmental catalogue number220181 220197
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: